PLEASANTON, Calif., Jan. 3 /PRNewswire-FirstCall/ -- Thoratec Corporation , a world leader in products to treat cardiovascular disease, said today that it will be participating in the JP Morgan Healthcare Conference on Wednesday, January 10.
Gary Burbach, president and chief executive officer, will provide an update on the company, beginning at 4:00 p.m., Pacific Standard Time (7 p.m., Eastern Standard Time).
The presentation will be available through the conference website at https://events.jpmorgan.com and on the company’s web site at http://www.thoratec.com .
Thoratec is a world leader in therapies to address advanced stage heart failure. The company’s product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company’s web sites at
Thoratec Corporation
CONTACT: Neal Rosen of Kalt Rosen & Co., +1-415-397-2686, for ThoratecCorporation
